More PegBio Co., Ltd. news
PegBio Co., Ltd.HKEX: 2565

Next Day Disclosure Return

Nov 10, 2026 at 5:12 AM EST · Issued by PegBio Co., Ltd. via HKEXnews

Filed with HKEX · Stock code 2565 · Nov 10, 2026 at 5:12 AM EST · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-2498

PegBio Co., Ltd. on 6ix

Earlier from PegBio

  • Completion of placing of new h shares under general mandateNov 10
  • Cancellation of extraordinary general meeting and cancellation of book closure periodNov 6
  • Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 4
  • Placing of new h shares under general mandateNov 2
  • Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 12, 2026Oct 23

Later from PegBio

  • (1) Proposed removal of auditor (2) proposed appointment of auditor (3) proposed change in use of proceeds from the global offering and (4) notice of the 2026 first extraordinary general meetingNov 11
  • Notice of the 2026 first extraordinary general meetingNov 11
  • Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 26, 2026Nov 11
  • Voluntary announcement successful inclusion of the group's core product paidakang (visepegenatide injection) into the 2026 NRDLNov 15
All PegBio news releases↗

Follow PegBio into a list and get an email when it puts out news.

Follow PegBio
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer